[go: up one dir, main page]

NO175188C - Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol - Google Patents

Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol

Info

Publication number
NO175188C
NO175188C NO902871A NO902871A NO175188C NO 175188 C NO175188 C NO 175188C NO 902871 A NO902871 A NO 902871A NO 902871 A NO902871 A NO 902871A NO 175188 C NO175188 C NO 175188C
Authority
NO
Norway
Prior art keywords
preparing
ability
peptide conjugate
cell cytosol
penetrate cell
Prior art date
Application number
NO902871A
Other languages
Norwegian (no)
Other versions
NO902871L (en
NO175188B (en
NO902871D0 (en
Inventor
Sjur Olsnes
Original Assignee
Sjur Olsnes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sjur Olsnes filed Critical Sjur Olsnes
Priority to NO902871A priority Critical patent/NO175188C/en
Publication of NO902871D0 publication Critical patent/NO902871D0/en
Priority to PCT/NO1991/000093 priority patent/WO1992000099A1/en
Priority to EP91911315A priority patent/EP0542756A1/en
Priority to HU924125A priority patent/HUT63061A/en
Priority to AU80001/91A priority patent/AU653158C/en
Priority to FI925869A priority patent/FI925869A7/en
Priority to JP3510777A priority patent/JPH06503552A/en
Priority to CA002086342A priority patent/CA2086342A1/en
Publication of NO902871L publication Critical patent/NO902871L/en
Priority to LTIP835A priority patent/LTIP835A/en
Publication of NO175188B publication Critical patent/NO175188B/no
Publication of NO175188C publication Critical patent/NO175188C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO902871A 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol NO175188C (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol
CA002086342A CA2086342A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into a cytosol
AU80001/91A AU653158C (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol
EP91911315A EP0542756A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol
HU924125A HUT63061A (en) 1990-06-27 1991-06-26 Process for entering peptide in cytosol
PCT/NO1991/000093 WO1992000099A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol
FI925869A FI925869A7 (en) 1990-06-27 1991-06-26 A method for introducing a peptide into the cell membrane
JP3510777A JPH06503552A (en) 1990-06-27 1991-06-26 How to introduce peptides into the cytosol
LTIP835A LTIP835A (en) 1990-06-27 1993-08-03 Method of introducting a peptide into the cytosol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol

Publications (4)

Publication Number Publication Date
NO902871D0 NO902871D0 (en) 1990-06-27
NO902871L NO902871L (en) 1991-12-30
NO175188B NO175188B (en) 1994-06-06
NO175188C true NO175188C (en) 1994-09-14

Family

ID=19893304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol

Country Status (8)

Country Link
EP (1) EP0542756A1 (en)
JP (1) JPH06503552A (en)
CA (1) CA2086342A1 (en)
FI (1) FI925869A7 (en)
HU (1) HUT63061A (en)
LT (1) LTIP835A (en)
NO (1) NO175188C (en)
WO (1) WO1992000099A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
EP1715047A3 (en) * 1992-04-21 2008-08-27 Institut Pasteur Recombinant mutants for inducing specific immune responses
US5935580A (en) * 1992-04-21 1999-08-10 Institut Pasteur Recombinant mutants for inducing specific immune responses
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US6777546B2 (en) 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
US7422747B2 (en) 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US6004815A (en) * 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
EP1254156A4 (en) * 2000-01-27 2003-05-21 Univ Loma Linda TRANSGENE PLANT-BASED VACCINE
EP1188446B1 (en) 2000-09-15 2009-08-05 Institut Pasteur Proteinaceous vectors for molecule delivery to CD11b expressing cells
GB0524408D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
AU2017230792B2 (en) * 2016-03-10 2023-08-10 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE25197T1 (en) * 1982-05-12 1987-02-15 Harvard College FUSIONED GENES ENCODING HYBRID PROTEIN, CLONING VECTORS CONTAINING THEM AND THEIR USE.
FR2532850B1 (en) * 1982-09-15 1985-12-20 Pasteur Institut IMMUNOGENIC CONJUGATES BETWEEN A HAPTENA AND A CARRIER MOLECULE DERIVED FROM A TOXIN, THE VACCINES CONTAINING THEM AND PROCESS FOR OBTAINING THEM
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IL89504A0 (en) * 1988-03-08 1989-09-10 Univ Wyoming Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
FR2636842B1 (en) * 1988-09-27 1994-06-10 Liege Universite Etat FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE
AU657087B2 (en) * 1989-12-22 1995-03-02 Seragen Incorporated Hybrid molecules having translocation region and cell-binding region

Also Published As

Publication number Publication date
FI925869A0 (en) 1992-12-23
WO1992000099A1 (en) 1992-01-09
FI925869L (en) 1992-12-23
NO902871L (en) 1991-12-30
AU653158B2 (en) 1994-09-22
HUT63061A (en) 1993-07-28
NO175188B (en) 1994-06-06
EP0542756A1 (en) 1993-05-26
LTIP835A (en) 1995-02-27
AU8000191A (en) 1992-01-23
HU9204125D0 (en) 1993-04-28
JPH06503552A (en) 1994-04-21
FI925869A7 (en) 1992-12-23
NO902871D0 (en) 1990-06-27
CA2086342A1 (en) 1991-12-28

Similar Documents

Publication Publication Date Title
NO175188C (en) Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol
DE69012008D1 (en) Preparation of a lump of cells.
FI981807L (en) Method for preparing therapeutically useful starburst conjugates
AU497333B2 (en) Manifold for solar collector
AU8053687A (en) Improved photovoltaic heterojunction structures
DE68922314D1 (en) SYNERGIC FUEL COMPOSITION.
RO102513B1 (en) Composition for improving plants growing
PH16096A (en) Stable radiografhic scanning agents and a method for the preparation thereof
GB2236588B (en) Improved fuel vapouriser
NZ217405A (en) Thermoforming by supporting material until plastic then allowing to form
ITTO910894A1 (en) "A PROCEDURE TO PREPARE DIPEPTIDES".
DE68907938D1 (en) CONTAINER FOR CELL CULTURES.
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
FI925260L (en) Process for preparing therapeutically useful 6-amino-substituted octahydro-1,7,8-indolizinetriol derivatives
MY8400086A (en) A pharmaceutically active benzothiadiazole derivative
IL61702A0 (en) Pharmacologically active peptides
IL61703A0 (en) Pharmacologically active peptides
IL61700A0 (en) Pharmacologically active peptides
AU585122B2 (en) Improved fuel composition
AR245079A1 (en) Procedure for preparing peroxomonosulphuric acid.
IL61701A0 (en) Pharmacologically active peptides
GB8821094D0 (en) Easy disconnect motion decoupling top joint for otec
FI911282L (en) Process for preparing novel therapeutically useful 3,4-dihydroxy-2,5-dihydrofuranones
ZM1579A1 (en) Process for the preparation of a 1,2-dioxime process for the preparation o a 1,2 dioxime
FI874852L (en) Analogous method for preparing a cytotoxic composition